
CVS Restores Obesity Drug Access for 10 Million Americans
More than 10 million Americans just regained insurance coverage for a life-changing obesity treatment after CVS reversed its restrictions on Zepbound. The win came after drugmaker Eli Lilly slashed prices to make the medication more accessible.





